WO2017107628A1 - Chitosan oligosaccharide capsule and method for preparation thereof - Google Patents

Chitosan oligosaccharide capsule and method for preparation thereof Download PDF

Info

Publication number
WO2017107628A1
WO2017107628A1 PCT/CN2016/102114 CN2016102114W WO2017107628A1 WO 2017107628 A1 WO2017107628 A1 WO 2017107628A1 CN 2016102114 W CN2016102114 W CN 2016102114W WO 2017107628 A1 WO2017107628 A1 WO 2017107628A1
Authority
WO
WIPO (PCT)
Prior art keywords
chitosan oligosaccharide
capsule
parts
thickener
plasticizer
Prior art date
Application number
PCT/CN2016/102114
Other languages
French (fr)
Chinese (zh)
Inventor
苏政权
郭姣
黄兰兰
Original Assignee
广东药科大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广东药科大学 filed Critical 广东药科大学
Publication of WO2017107628A1 publication Critical patent/WO2017107628A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material

Definitions

  • the invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a chitosan oligosaccharide capsule and a preparation method thereof.
  • Chitosan naoligosaccharide is a homopolymer or heteropolymer of glucosamine and N-acetylglucosamine linked by ⁇ -1,4 glycosidic bonds.
  • COS is the only abundant organic polysaccharide in natural sugar. In addition to its chitosan-like properties, it also has the advantages of low viscosity, good water solubility, small molecular weight, easy absorption and degradability, and its biological activity and function. The properties are superior to chitosan.
  • a large number of studies have shown that COS has the functions of regulating blood sugar, blood sugar, anti-oxidation, anti-infection, enhancing immunity and anti-tumor. It is an ideal bioactive substance with broad medical application prospects.
  • Chinese patent CN103316031B discloses a slimming and lipid-lowering application of chitosan oligosaccharide, which has a remarkable application effect in controlling body weight, reducing body fat ratio and lowering serum total cholesterol and low density lipoprotein cholesterol content, indicating shell Oligosaccharides have significant weight loss and lipid-lowering effects, and also have the function of relieving fatty liver and reducing blood lipids in serum.
  • chitosan oligosaccharides have the characteristics of low molecular weight, easy moisture absorption, and easy oxidation, their application in the field of health care products or medicines is greatly limited. At present, the application of chitosan oligosaccharides is mainly focused on crops.
  • Chinese patent CN102613197B discloses the use of chitosan oligosaccharide for preventing premature aging, which can effectively prevent premature aging of crops and ensure stable yield and income of agriculture.
  • Chinese patent CN101818181B discloses a method for enzymatically preparing agricultural chitosan oligosaccharide and a crop nutrient preparation containing chitooligosaccharide, which can not only provide nutrition for crops, stimulate crop growth, but also inhibit the reproduction of harmful bacteria and improve the crop itself. Disease resistance.
  • the object of the present invention is to provide a chitosan oligosaccharide capsule and a preparation method thereof to solve the above defects.
  • the present invention provides a chitosan oligosaccharide capsule comprising a content and a capsule comprising the following components and their weight percentages: chitosan oligosaccharide 80-100%, microcrystalline cellulose 0-6%, bonding Agent 0-5%, calcium stearate 0-3%, ethanol 0-4% and micronized silica gel 0-2%;
  • the capsule comprises the following components and parts by weight: 4-10 parts of hydroxypropyl starch, 2-6 parts of xanthan gum, 4-8 parts of thickener, 3-6 parts of plasticizer and 10 parts of water. 20 copies.
  • the content includes the following components and their weight percentages: chitosan oligosaccharide 80-92%, microcrystalline cellulose 2-6%, binder 2-5%, calcium stearate 1-3%, ethanol 2-4% and micronized silica gel 1-2%.
  • the contents include the following components and their weight percentages: chitosan oligosaccharide 85.5%, microcrystalline cellulose 4%, binder 4%, calcium stearate 2%, ethanol 3%, and micronized silica gel 1.5% .
  • the binder is a povidone solution having a concentration of 5%
  • the ethanol is anhydrous ethanol.
  • the capsule comprises the following components and parts by weight: 8 parts of hydroxypropyl starch, 4 parts of xanthan gum, 5 parts of thickener, 4 parts of plasticizer and 16 parts of water.
  • the thickener is composed of guar gum and propylene glycol alginate in a weight ratio of 1-2:3-4, preferably, the thickener is composed of guar gum and propylene glycol alginate by weight. It is composed of 1.2:3.5.
  • the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 2-4:1-3, preferably, the plasticizer is 3.5:2 by weight of glycerin and triethyl citrate. composition.
  • the content of the capsule provided by the invention adopts a povidone solution having a concentration of 5% as a binder, which can improve the uniformity of the particles without occurrence of the phenomenon that the particles cannot be granulated, the particles are loose or agglomerated.
  • the use of anhydrous ethanol as a wetting agent can prevent the appearance of mushy or lumps of chitosan oligosaccharides.
  • the composition of the capsule contents provided by the invention is reasonable, and the prepared contents are dry, moderately tight, and the moisture content is qualified, which complies with the relevant provisions of the Chinese Pharmacopoeia on the contents of the capsules.
  • the hydroxypropyl starch in the capsule provided by the invention has the formula C 3 H 8 O 2 ⁇ x, the CAS number is 9049-76-7, and has the advantages of high stability, good expandability and good film forming property, yellow
  • the original rubber has the advantages of high viscosity, good thermal stability and acid-base stability, and is an ideal bio-adhesive.
  • the combination of hydroxypropyl starch and xanthan gum can improve the gelation and gel temperature of hydroxypropyl starch, which is beneficial to the film formation of hydroxypropyl starch.
  • the guar gum in the capsule provided by the present invention is a nonionic galactomannan which has good water solubility and exhibits a high viscosity at a low mass fraction.
  • the propylene glycol alginate is a deep-processed alginic acid extracted from natural seaweed, which does not gel in an acidic solution, and is an environmentally-friendly thickener.
  • the combination of guar gum and propylene glycol alginate in a certain proportion can greatly enhance the thickening effect of propylene glycol alginate.
  • Glycerin has the characteristics of low viscosity, easy dispersion and good compatibility, while triethyl citrate has the advantages of strong solubility and good mold resistance. Glycerin and triethyl citrate are used in combination in a certain ratio to have a remarkable plasticizing effect.
  • the capsules provided by the invention have reasonable distribution, and the prepared capsules have no odor, the appearance is neat, no sticking, deformation, leakage or capsule rupture, and the sealing property is good, the oxidation resistance is high, and the improvement is greatly improved.
  • the stability of the capsule is beneficial to the preservation of the capsule.
  • the present invention also provides a method for preparing a chitosan oligosaccharide capsule, comprising the following steps:
  • S1 grinds chitosan oligosaccharide, microcrystalline cellulose, calcium stearate and micro-powder silica gel into a fine powder, and mixes with a binder and ethanol to pass through a sieve of 18-25 mesh to obtain a fine powder;
  • the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 22-28 ° C, the humidity is 35-45%, and the granulation is dried to less than 10% moisture to obtain a content;
  • S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, thickener, plasticizer and water to mix evenly, and dries at a temperature of 55-60 ° C for 4-5 h, then at a temperature of 50 ° C Carrying out silicone, drying, demoulding, cutting, nesting, and obtaining a capsule;
  • step S4 the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
  • the chitosan oligosaccharide capsule provided by the present invention has the following advantages:
  • the chitosan oligosaccharide capsule provided by the invention has no odor, has a neat appearance, is smooth, and has high solubility, and is beneficial to the effect of medicine, and is an ideal chitosan oligosaccharide capsule;
  • the chitosan oligosaccharide capsule provided by the invention has good sealing property and high oxidation resistance, and can effectively solve the problem that the chitosan oligosaccharide is easy to oxidize and absorb moisture, and is beneficial to the long-term preservation of chitooligosaccharide.
  • Example 1 A chitosan oligosaccharide capsule
  • the content is 100% chitosan oligosaccharide
  • the capsule comprises the following components and parts by weight: hydroxypropyl starch 8 parts, xanthan gum 4 parts, thickener 5 parts, plasticizer 4 parts and water 16 parts; the thickener is made of melon
  • the guar gum and the propylene glycol alginate were composed at a weight ratio of 1.2:3.5, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 3.5:2.
  • S1 grinds the chitosan oligosaccharide into a fine powder and passes through a 20 mesh sieve to obtain a fine powder;
  • the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 25 ° C, the humidity is 40%, and the granulation is dried to less than 10% moisture to obtain a content;
  • S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, a thickener, a plasticizer and water to mix uniformly, and dries at a temperature of 60 ° C for 4 h, and then writes the tannin at a temperature of 50 ° C. Drying, demoulding, cutting, nesting, obtaining a capsule;
  • step S4 the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
  • Example 2 A chitosan oligosaccharide capsule
  • the contents include the following components and their weight percentages: chitosan oligosaccharide 92%, microcrystalline cellulose 2%, 5% povidone solution 2%, calcium stearate 1%, absolute ethanol 2%, and fine powder Silicone 1%;
  • the capsule comprises the following components and parts by weight: 4 parts of hydroxypropyl starch, 2 parts of xanthan gum, 4 parts of thickener, 3 parts of plasticizer and 10 parts of water; the thickener is made of melon
  • the guar gum and the propylene glycol alginate were composed at a weight ratio of 1:4, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 2:3.
  • S1 grinds chitosan oligosaccharide, microcrystalline cellulose, calcium stearate and micro-powder silica gel into fine powder, and mixes with 5% povidone solution and absolute ethanol, and passes through a 20 mesh sieve to obtain a fine powder;
  • the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 25 ° C, the humidity is 40%, and the granulation is dried to less than 10% moisture to obtain a content;
  • S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, a thickener, a plasticizer and water to mix uniformly, and dries at a temperature of 60 ° C for 4 h, and then writes the tannin at a temperature of 50 ° C. Drying, demoulding, cutting, nesting, obtaining a capsule;
  • step S4 the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
  • Example 3 a chitosan oligosaccharide capsule
  • the contents include the following components and their weight percentages: chitosan oligosaccharide 85.5%, microcrystalline cellulose 4%, 5% povidone solution 4%, calcium stearate 2%, anhydrous ethanol 3%, and fine powder Silicone 1.5%;
  • the capsule comprises the following components and parts by weight: hydroxypropyl starch 8 parts, xanthan gum 4 parts, thickener 5 parts, plasticizer 4 parts and water 16 parts; the thickener is made of melon
  • the guar gum and the propylene glycol alginate were composed at a weight ratio of 1.2:3.5, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 3.5:2.
  • the preparation method was similar to that of Example 2.
  • Example 4 a chitosan oligosaccharide capsule
  • the contents include the following components and their weight percentages: chitosan oligosaccharide 80%, microcrystalline cellulose 6%, 5% povidone solution 5%, calcium stearate 3%, absolute ethanol 4%, and fine powder Silicone 2%;
  • the capsule comprises the following components and parts by weight: 10 parts of hydroxypropyl starch, 6 parts of xanthan gum, 8 parts of thickener, 6 parts of plasticizer and 20 parts of water; the thickener is made of melon
  • the guar gum and the propylene glycol alginate were composed at a weight ratio of 2:3, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 4:1.
  • the preparation method was similar to that of Example 2.
  • the thickener is composed of guar gum and propylene glycol alginate at a weight ratio of 3:2, and the remaining components are as in Example 3.
  • the preparation method was similar to that of Example 2.
  • the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 1:4, and the remaining components are as in Example 3.
  • the preparation method was similar to that of Example 2.
  • Test materials Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2.
  • the contents of the shell oligosaccharide capsules prepared in Examples 1-4 of the present invention are dry, moderately tight, and the moisture content is less than 9.0%, and the capsule has no peculiar smell, and the appearance is neat, without sticking, deformation, and seepage.
  • Leakage or capsule rupture, its loading difference and solubility are in line with the relevant provisions of the Chinese Pharmacopoeia, while the capsules prepared in Comparative Example 1 and Comparative Example 2 have irregularities in appearance, such as sticking, deformation, leakage or rupture of the shell.
  • the dissolution rate is less than 90% at 45 min, which does not comply with the relevant regulations of the Chinese Pharmacopoeia, indicating that the capsule formulation provided by the invention is reasonable, can greatly improve the product quality, and promote the promotion and application of the chitosan oligosaccharide capsule.
  • Test materials Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2.
  • the chitosan oligosaccharide capsules prepared in Examples 1-4 of the present invention are placed under the conditions of temperature of 40 ° C ⁇ 2 ° C and relative humidity of 75% ⁇ 5% for 6 months, and the indexes thereof are all in accordance with The quality requirements of the Chinese Pharmacopoeia for the capsules, while the stability of the chitosan oligosaccharide capsules prepared in Comparative Example 1 and Comparative Example 2 were inferior to those of the chitosan oligosaccharide capsules prepared in Examples 1-4, indicating the shell oligomer provided by the present invention.
  • the formula of the sugar capsule is reasonable, and the stability of the chitosan oligosaccharide capsule is greatly improved.
  • Test Example 3 Long-term test of chitosan oligosaccharide capsules
  • Test materials Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3 and Example 4.
  • Example 1 The chitosan oligosaccharide capsules prepared in Example 1, Example 2, Example 3 and Example 4 were subjected to long-term tests with reference to the test method of "Chinese Pharmacopoeia 2010 Edition Part II Appendix XIX C".

Abstract

The present disclosure belongs to the technical field of pharmaceutical preparations and specifically relates to a chitosan oligosaccharide capsule and method for preparation thereof. The chitosan oligosaccharide capsule comprises content and a capsule shell; said content consists primarily of chitosan oligosaccharide, microcrystalline cellulose, adhesive, calcium stearate, ethanol, and micropowder silicone; said capsule shell consists primarily of hydroxypropyl starch, xanthan gum, thickener, plasticizer, and water. The chitosan oligosaccharide capsule is odorless, has a neat appearance, and is smooth; its content uniformity and solubility satisfy the relevant provisions of the Pharmacopoeia of China, and the capsule has relatively good sealing tightness and resistance to oxidation; it effectively addresses the problem of chitosan oligosaccharide being prone to oxidation and moisture absorption, facilitating the long-term storage of chitosan oligosaccharide.

Description

一种壳寡糖胶囊剂及其制备方法Shell oligosaccharide capsule and preparation method thereof 技术领域Technical field
本发明属于医药制剂技术领域,具体涉及一种壳寡糖胶囊剂及其制备方法。The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a chitosan oligosaccharide capsule and a preparation method thereof.
背景技术Background technique
壳寡糖(chtiosnaoligosaccharide,COS)是氨基葡萄糖和N-乙酰氨基葡萄糖以β-1,4糖苷键连接而成的同聚物或异聚物。COS是天然糖中唯一大量存在的碱性多糖,除了具有类似壳聚糖的性质外,其还具有粘度低,水溶性好,分子量小,容易吸收利用及可降解等优点,其生物活性及功能性质都比壳聚糖更加优越。大量研究表明,COS具有调节血糖血脂,抗氧化,抗感染,增强免疫力和抗肿瘤等功能,是一种较为理想的生物活性物质,具有广阔的医药应用前景。Chitosan naoligosaccharide (COS) is a homopolymer or heteropolymer of glucosamine and N-acetylglucosamine linked by β-1,4 glycosidic bonds. COS is the only abundant organic polysaccharide in natural sugar. In addition to its chitosan-like properties, it also has the advantages of low viscosity, good water solubility, small molecular weight, easy absorption and degradability, and its biological activity and function. The properties are superior to chitosan. A large number of studies have shown that COS has the functions of regulating blood sugar, blood sugar, anti-oxidation, anti-infection, enhancing immunity and anti-tumor. It is an ideal bioactive substance with broad medical application prospects.
中国专利CN103316031B公开了壳寡糖的减肥降脂应用,所述壳寡糖在控制体重、减少体脂比及降低血清中总胆固醇和低密度脂蛋白胆固醇含量等方面具有显著的应用效果,表明壳寡糖具有显著的减肥、降脂功效,同时还具有缓解脂肪肝,减少血清中的血脂的功能。Chinese patent CN103316031B discloses a slimming and lipid-lowering application of chitosan oligosaccharide, which has a remarkable application effect in controlling body weight, reducing body fat ratio and lowering serum total cholesterol and low density lipoprotein cholesterol content, indicating shell Oligosaccharides have significant weight loss and lipid-lowering effects, and also have the function of relieving fatty liver and reducing blood lipids in serum.
陈健发表了一篇题目为“壳寡糖、氨基葡萄糖减肥活性及载辣椒碱壳聚糖微球肠溶片的研究”的论文,该论文表明壳寡糖具有较好的减肥效果,而且还具有无毒副作用、吸收快和生相容性好优点,是一种理想减肥药物。Chen Jian published a paper titled "Study on chitosan oligosaccharide, glucosamine slimming activity and capsaicin-containing chitosan microsphere enteric-coated tablets", which showed that chitosan oligosaccharides have better weight loss effects, but also It has the advantages of no toxic side effects, fast absorption and good compatibility. It is an ideal weight loss drug.
然而,由于壳寡糖具有分子量低、容易吸潮、易氧化的特点,大大的限制了其在保健品或药品领域中的应用。目前,壳寡糖的应用主要集中于农作物方面。中国专利CN102613197B公开了壳寡糖应用于抗早衰的用途,所述壳寡糖能够有效的防治作物的早衰,保证农业的稳产增收。中国专利CN101818181B公开了酶解制备农用壳寡糖的方法及含有壳寡糖的作物营养制剂,该营养制剂不仅可以为作物提供营养,刺激作物生长,而且还可以抑制有害菌的繁殖,提高作物自身抗病能力。However, since chitosan oligosaccharides have the characteristics of low molecular weight, easy moisture absorption, and easy oxidation, their application in the field of health care products or medicines is greatly limited. At present, the application of chitosan oligosaccharides is mainly focused on crops. Chinese patent CN102613197B discloses the use of chitosan oligosaccharide for preventing premature aging, which can effectively prevent premature aging of crops and ensure stable yield and income of agriculture. Chinese patent CN101818181B discloses a method for enzymatically preparing agricultural chitosan oligosaccharide and a crop nutrient preparation containing chitooligosaccharide, which can not only provide nutrition for crops, stimulate crop growth, but also inhibit the reproduction of harmful bacteria and improve the crop itself. Disease resistance.
因此,研究和开出一种稳定性好、抗氧化性高的壳寡糖剂型是促进壳寡糖在保健品或药品领域中应用的有效途径。Therefore, researching and developing a chitosan oligosaccharide dosage form with good stability and high oxidation resistance is an effective way to promote the application of chitosan oligosaccharide in the field of health care products or medicines.
发明内容Summary of the invention
为了解决现有技术中壳寡糖存在的分子量低、容易吸潮、易氧化的缺陷,本发明的目的在于提供一种壳寡糖胶囊剂及其制备方法,以解决上述缺陷。 In order to solve the defects of low molecular weight, easy moisture absorption and easy oxidation in the prior art, the object of the present invention is to provide a chitosan oligosaccharide capsule and a preparation method thereof to solve the above defects.
本发明提供了一种壳寡糖胶囊剂,包括内容物和囊壳,所述内容物包括如下组分及其重量百分比:壳寡糖80-100%、微晶纤维素0-6%、黏合剂0-5%、硬脂酸钙0-3%、乙醇0-4%和微粉硅胶0-2%;The present invention provides a chitosan oligosaccharide capsule comprising a content and a capsule comprising the following components and their weight percentages: chitosan oligosaccharide 80-100%, microcrystalline cellulose 0-6%, bonding Agent 0-5%, calcium stearate 0-3%, ethanol 0-4% and micronized silica gel 0-2%;
所述囊壳包括如下组分及其重量份数:羟丙基淀粉4-10份、黄原胶2-6份、增稠剂4-8份、增塑剂3-6份和水10-20份。The capsule comprises the following components and parts by weight: 4-10 parts of hydroxypropyl starch, 2-6 parts of xanthan gum, 4-8 parts of thickener, 3-6 parts of plasticizer and 10 parts of water. 20 copies.
进一步地,所述内容物包括如下组分及其重量百分比:壳寡糖80-92%、微晶纤维素2-6%、黏合剂2-5%、硬脂酸钙1-3%、乙醇2-4%和微粉硅胶1-2%。Further, the content includes the following components and their weight percentages: chitosan oligosaccharide 80-92%, microcrystalline cellulose 2-6%, binder 2-5%, calcium stearate 1-3%, ethanol 2-4% and micronized silica gel 1-2%.
更进一步地,所述内容物包括如下组分及其重量百分比:壳寡糖85.5%、微晶纤维素4%、黏合剂4%、硬脂酸钙2%、乙醇3%和微粉硅胶1.5%。Further, the contents include the following components and their weight percentages: chitosan oligosaccharide 85.5%, microcrystalline cellulose 4%, binder 4%, calcium stearate 2%, ethanol 3%, and micronized silica gel 1.5% .
进一步地,所述黏合剂为浓度为5%的聚维酮溶液,所述乙醇为无水乙醇。Further, the binder is a povidone solution having a concentration of 5%, and the ethanol is anhydrous ethanol.
进一步地,所述囊壳包括如下组分及其重量份数:羟丙基淀粉8份、黄原胶4份、增稠剂5份、增塑剂4份和水16份。Further, the capsule comprises the following components and parts by weight: 8 parts of hydroxypropyl starch, 4 parts of xanthan gum, 5 parts of thickener, 4 parts of plasticizer and 16 parts of water.
进一步地,所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1-2:3-4组成,优选地,所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1.2:3.5组成。Further, the thickener is composed of guar gum and propylene glycol alginate in a weight ratio of 1-2:3-4, preferably, the thickener is composed of guar gum and propylene glycol alginate by weight. It is composed of 1.2:3.5.
进一步地,所述增塑剂由甘油和柠檬酸三乙酯按重量比2-4:1-3组成,优选地,所述增塑剂由甘油和柠檬酸三乙酯按重量比3.5:2组成。Further, the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 2-4:1-3, preferably, the plasticizer is 3.5:2 by weight of glycerin and triethyl citrate. composition.
本发明提供的胶囊剂内容物采用浓度为5%的聚维酮溶液作为黏合剂,可以提高颗粒的均匀度,不会出现无法成粒、粒松散或结块的现象。选用无水乙醇作为湿润剂,可以防止壳寡糖出现糊状或结成团的现象。本发明提供的胶囊剂内容物的各组分配伍合理,制备得到的内容物干燥、松紧适度,水分含量合格,符合中国药典对胶囊剂内容物的相关规定。The content of the capsule provided by the invention adopts a povidone solution having a concentration of 5% as a binder, which can improve the uniformity of the particles without occurrence of the phenomenon that the particles cannot be granulated, the particles are loose or agglomerated. The use of anhydrous ethanol as a wetting agent can prevent the appearance of mushy or lumps of chitosan oligosaccharides. The composition of the capsule contents provided by the invention is reasonable, and the prepared contents are dry, moderately tight, and the moisture content is qualified, which complies with the relevant provisions of the Chinese Pharmacopoeia on the contents of the capsules.
本发明提供的囊壳中的羟丙基淀粉的分子式为C3H8O2·x,CAS号为9049-76-7,其具有稳定性高,膨胀性和成膜特性好的优点,黄原胶具有粘度高、良好的热稳定性和酸碱稳定性的优点,是一种较为理想的生物胶。羟丙基淀粉与黄原胶复配使用可以提高羟丙基淀粉的凝胶性和凝胶温度,有利于羟丙基淀粉的成膜。The hydroxypropyl starch in the capsule provided by the invention has the formula C 3 H 8 O 2 ·x, the CAS number is 9049-76-7, and has the advantages of high stability, good expandability and good film forming property, yellow The original rubber has the advantages of high viscosity, good thermal stability and acid-base stability, and is an ideal bio-adhesive. The combination of hydroxypropyl starch and xanthan gum can improve the gelation and gel temperature of hydroxypropyl starch, which is beneficial to the film formation of hydroxypropyl starch.
本发明提供的囊壳中的瓜尔豆胶是一种非离子型半乳甘露聚糖,其具有较好的水溶性,且在低质量分数下呈现较高的粘度的优点。藻酸丙二醇酯是从天然海藻中提取的海藻酸深加工制成,其在酸性溶液中不会凝胶化,是一种环保型的增稠剂。瓜尔豆胶与藻酸丙二醇酯在一定比例范围内联合使用,可以大大增强藻酸丙二醇酯的增稠作用。甘油具有黏度低、易分散,相容性好的特点,而柠檬酸三乙酯具有溶解性强和抗霉性好的优点。甘油与柠檬酸三乙酯在一定比例范围内联合使用,具有显著的增塑效果。 The guar gum in the capsule provided by the present invention is a nonionic galactomannan which has good water solubility and exhibits a high viscosity at a low mass fraction. The propylene glycol alginate is a deep-processed alginic acid extracted from natural seaweed, which does not gel in an acidic solution, and is an environmentally-friendly thickener. The combination of guar gum and propylene glycol alginate in a certain proportion can greatly enhance the thickening effect of propylene glycol alginate. Glycerin has the characteristics of low viscosity, easy dispersion and good compatibility, while triethyl citrate has the advantages of strong solubility and good mold resistance. Glycerin and triethyl citrate are used in combination in a certain ratio to have a remarkable plasticizing effect.
本发明提供的囊壳各组分配伍合理,制备得到的囊壳无异臭,外观整洁,没有黏结、变形、渗漏或囊壳破裂现象,而且密封性好、抗氧化性高,大大的提高了胶囊剂的稳定性,有利于该胶囊剂的保存。The capsules provided by the invention have reasonable distribution, and the prepared capsules have no odor, the appearance is neat, no sticking, deformation, leakage or capsule rupture, and the sealing property is good, the oxidation resistance is high, and the improvement is greatly improved. The stability of the capsule is beneficial to the preservation of the capsule.
另外,本发明还提供了一种壳寡糖胶囊剂的制备方法,包括以下步骤:In addition, the present invention also provides a method for preparing a chitosan oligosaccharide capsule, comprising the following steps:
S1将壳寡糖、微晶纤维素、硬脂酸钙和微粉硅胶研磨成细粉,加入黏合剂和乙醇混合均匀,过18-25目筛,得细粉;S1 grinds chitosan oligosaccharide, microcrystalline cellulose, calcium stearate and micro-powder silica gel into a fine powder, and mixes with a binder and ethanol to pass through a sieve of 18-25 mesh to obtain a fine powder;
S2将步骤S1得到的细粉进行湿法制粒,所述湿法制粒的温度为22-28℃,湿度为35-45%,制粒后干燥至水分少于10%,得内容物;S2, the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 22-28 ° C, the humidity is 35-45%, and the granulation is dried to less than 10% moisture to obtain a content;
S3将羟丙基淀粉研磨成细粉,加入黄原胶、增稠剂、增塑剂和水混合均匀,在温度为55-60℃的条件下干燥4-5h,接着在温度为50℃下进行蘸胶,烘干,脱模,切割,套合,得囊壳;S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, thickener, plasticizer and water to mix evenly, and dries at a temperature of 55-60 ° C for 4-5 h, then at a temperature of 50 ° C Carrying out silicone, drying, demoulding, cutting, nesting, and obtaining a capsule;
S4将步骤S2得到的内容物灌装到步骤S3得到的囊壳中,将胶囊密封,即得。S4, the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
与现有技术相比,本发明提供的壳寡糖胶囊剂具有以下优势:Compared with the prior art, the chitosan oligosaccharide capsule provided by the present invention has the following advantages:
(1)本发明提供的壳寡糖胶囊剂无异味,外观整洁、光滑,而且溶解度高,利于药效的发挥,是一种较为理想的壳寡糖胶囊剂;(1) The chitosan oligosaccharide capsule provided by the invention has no odor, has a neat appearance, is smooth, and has high solubility, and is beneficial to the effect of medicine, and is an ideal chitosan oligosaccharide capsule;
(2)本发明提供的壳寡糖胶囊剂密封性好、抗氧化性高,可以有效的解决了壳寡糖易于氧化和吸潮的问题,有利于壳寡糖的长期保存。(2) The chitosan oligosaccharide capsule provided by the invention has good sealing property and high oxidation resistance, and can effectively solve the problem that the chitosan oligosaccharide is easy to oxidize and absorb moisture, and is beneficial to the long-term preservation of chitooligosaccharide.
具体实施方式:detailed description:
以下通过具体实施方式的描述对本发明作进一步说明,但这并非是对本发明的限制,本领域技术人员根据本发明的基本思想,可以做出各种修改或改进,但是只要不脱离本发明的基本思想,均在本发明的范围之内。The invention is further illustrated by the following description of the specific embodiments, but this is not a limitation of the invention, and various modifications and improvements can be made by those skilled in the art based on the basic idea of the invention, without departing from the basic scope of the invention. Ideas are within the scope of the invention.
实施例1、一种壳寡糖胶囊剂Example 1. A chitosan oligosaccharide capsule
所述内容物为100%的壳寡糖;The content is 100% chitosan oligosaccharide;
所述囊壳包括如下组分及其重量份数:羟丙基淀粉8份、黄原胶4份、增稠剂5份、增塑剂4份和水16份;所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1.2:3.5组成,所述增塑剂由甘油和柠檬酸三乙酯按重量比3.5:2组成。The capsule comprises the following components and parts by weight: hydroxypropyl starch 8 parts, xanthan gum 4 parts, thickener 5 parts, plasticizer 4 parts and water 16 parts; the thickener is made of melon The guar gum and the propylene glycol alginate were composed at a weight ratio of 1.2:3.5, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 3.5:2.
制备方法:Preparation:
S1将壳寡糖研磨成细粉,过20目筛,得细粉; S1 grinds the chitosan oligosaccharide into a fine powder and passes through a 20 mesh sieve to obtain a fine powder;
S2将步骤S1得到的细粉进行湿法制粒,所述湿法制粒的温度25℃,湿度为40%,制粒后干燥至水分少于10%,得内容物;S2, the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 25 ° C, the humidity is 40%, and the granulation is dried to less than 10% moisture to obtain a content;
S3将羟丙基淀粉研磨成细粉,加入黄原胶、增稠剂、增塑剂和水混合均匀,在温度为60℃的条件下干燥4h,接着在温度为50℃写进行蘸胶,烘干,脱模,切割,套合,得囊壳;S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, a thickener, a plasticizer and water to mix uniformly, and dries at a temperature of 60 ° C for 4 h, and then writes the tannin at a temperature of 50 ° C. Drying, demoulding, cutting, nesting, obtaining a capsule;
S4将步骤S2得到的内容物灌装到步骤S3得到的囊壳中,将胶囊密封,即得。S4, the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
实施例2、一种壳寡糖胶囊剂Example 2: A chitosan oligosaccharide capsule
所述内容物包括如下组分及其重量百分比:壳寡糖92%、微晶纤维素2%、5%的聚维酮溶液2%、硬脂酸钙1%、无水乙醇2%和微粉硅胶1%;The contents include the following components and their weight percentages: chitosan oligosaccharide 92%, microcrystalline cellulose 2%, 5% povidone solution 2%, calcium stearate 1%, absolute ethanol 2%, and fine powder Silicone 1%;
所述囊壳包括如下组分及其重量份数:羟丙基淀粉4份、黄原胶2份、增稠剂4份、增塑剂3份和水10份;所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1:4组成,所述增塑剂由甘油和柠檬酸三乙酯按重量2:3组成。The capsule comprises the following components and parts by weight: 4 parts of hydroxypropyl starch, 2 parts of xanthan gum, 4 parts of thickener, 3 parts of plasticizer and 10 parts of water; the thickener is made of melon The guar gum and the propylene glycol alginate were composed at a weight ratio of 1:4, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 2:3.
制备方法:Preparation:
S1将壳寡糖、微晶纤维素、硬脂酸钙和微粉硅胶研磨成细粉,加入5%的聚维酮溶液和无水乙醇混合均匀,过20目筛,得细粉;S1 grinds chitosan oligosaccharide, microcrystalline cellulose, calcium stearate and micro-powder silica gel into fine powder, and mixes with 5% povidone solution and absolute ethanol, and passes through a 20 mesh sieve to obtain a fine powder;
S2将步骤S1得到的细粉进行湿法制粒,所述湿法制粒的温度25℃,湿度为40%,制粒后干燥至水分少于10%,得内容物;S2, the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 25 ° C, the humidity is 40%, and the granulation is dried to less than 10% moisture to obtain a content;
S3将羟丙基淀粉研磨成细粉,加入黄原胶、增稠剂、增塑剂和水混合均匀,在温度为60℃的条件下干燥4h,接着在温度为50℃写进行蘸胶,烘干,脱模,切割,套合,得囊壳;S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, a thickener, a plasticizer and water to mix uniformly, and dries at a temperature of 60 ° C for 4 h, and then writes the tannin at a temperature of 50 ° C. Drying, demoulding, cutting, nesting, obtaining a capsule;
S4将步骤S2得到的内容物灌装到步骤S3得到的囊壳中,将胶囊密封,即得。S4, the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
实施例3、一种壳寡糖胶囊剂Example 3, a chitosan oligosaccharide capsule
所述内容物包括如下组分及其重量百分比:壳寡糖85.5%、微晶纤维素4%、5%的聚维酮溶液4%、硬脂酸钙2%、无水乙醇3%和微粉硅胶1.5%;The contents include the following components and their weight percentages: chitosan oligosaccharide 85.5%, microcrystalline cellulose 4%, 5% povidone solution 4%, calcium stearate 2%, anhydrous ethanol 3%, and fine powder Silicone 1.5%;
所述囊壳包括如下组分及其重量份数:羟丙基淀粉8份、黄原胶4份、增稠剂5份、增塑剂4份和水16份;所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1.2:3.5组成,所述增塑剂由甘油和柠檬酸三乙酯按重量比3.5:2组成。The capsule comprises the following components and parts by weight: hydroxypropyl starch 8 parts, xanthan gum 4 parts, thickener 5 parts, plasticizer 4 parts and water 16 parts; the thickener is made of melon The guar gum and the propylene glycol alginate were composed at a weight ratio of 1.2:3.5, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 3.5:2.
制备方法与实施例2类似。The preparation method was similar to that of Example 2.
实施例4、一种壳寡糖胶囊剂Example 4, a chitosan oligosaccharide capsule
所述内容物包括如下组分及其重量百分比:壳寡糖80%、微晶纤维素6%、5%的聚维酮溶液5%、硬脂酸钙3%、无水乙醇4%和微粉硅胶2%; The contents include the following components and their weight percentages: chitosan oligosaccharide 80%, microcrystalline cellulose 6%, 5% povidone solution 5%, calcium stearate 3%, absolute ethanol 4%, and fine powder Silicone 2%;
所述囊壳包括如下组分及其重量份数:羟丙基淀粉10份、黄原胶6份、增稠剂8份、增塑剂6份和水20份;所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比2:3组成,所述增塑剂由甘油和柠檬酸三乙酯按重量比4:1组成。The capsule comprises the following components and parts by weight: 10 parts of hydroxypropyl starch, 6 parts of xanthan gum, 8 parts of thickener, 6 parts of plasticizer and 20 parts of water; the thickener is made of melon The guar gum and the propylene glycol alginate were composed at a weight ratio of 2:3, and the plasticizer was composed of glycerin and triethyl citrate in a weight ratio of 4:1.
制备方法与实施例2类似。The preparation method was similar to that of Example 2.
对比例1、一种壳寡糖胶囊剂Comparative Example 1, a chitosan oligosaccharide capsule
所述内容物的组分及其重量百分比如实施例3。The components of the contents and their weight percentages are as in Example 3.
所述囊壳的组分及其重量份数为:所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比3:2组成,其余组分如实施例3。The components of the capsule and parts by weight thereof are: the thickener is composed of guar gum and propylene glycol alginate at a weight ratio of 3:2, and the remaining components are as in Example 3.
制备方法与实施例2类似。The preparation method was similar to that of Example 2.
对比例2、一种壳寡糖胶囊剂Comparative Example 2, a chitosan oligosaccharide capsule
所述内容物的组分及其重量百分比如实施例3。The components of the contents and their weight percentages are as in Example 3.
所述囊壳的组分及其重量份数为:所述增塑剂由甘油和柠檬酸三乙酯按重量比1:4组成,其余组分如实施例3。The components of the capsule and the parts by weight thereof are: the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 1:4, and the remaining components are as in Example 3.
制备方法与实施例2类似。The preparation method was similar to that of Example 2.
试验例一、壳寡糖胶囊剂的质量检测试验Test Example 1. Quality Test of Shell Oligosaccharide Capsules
1、试验材料:实施例1、实施例2、实施例3、实施例4、对比例1和对比例2制备的壳寡糖胶囊剂。1. Test materials: Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2.
2、检测方法:2, detection method:
参考《中国药典2010年版二部》的检测方法,对实施例1、实施例2、实施例3、实施例4、对比例1和对比例2制备的壳寡糖胶囊剂的内容物状态和水分含量进行测定,同时对壳寡糖胶囊剂的外观、臭味、装量差异和溶解度进行检测,其中溶解度采用浆板法测量壳寡糖胶囊剂在45min时的溶出度。The contents and moisture of the chitosan oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2 were examined with reference to the detection method of "Chinese Pharmacopoeia 2010 Edition 2". The content was measured, and the appearance, odor, volume difference and solubility of the chitosan oligosaccharide capsules were examined. The solubility of the chitosan oligosaccharide capsules at 45 min was measured by the pulp method.
3、试验结果:3. Test results:
试验结果如表1所示。 The test results are shown in Table 1.
表1 壳寡糖胶囊剂的质量检测试验结果Table 1 Results of quality test of chitosan oligosaccharide capsules
Figure PCTCN2016102114-appb-000001
Figure PCTCN2016102114-appb-000001
由表1可知,本发明实施例1-4制备的壳寡糖胶囊剂的内容物状态干燥、松紧适度,水分含量小于9.0%,而且该胶囊剂无异味,外观整洁,无黏结、变形、渗漏或囊壳破裂现象,其装量差异和溶解度均符合中国药典的相关规定,而对比例1和对比例2制备的胶囊剂的外观有凹凸,有黏结、变形、渗漏或囊壳破裂现象,溶出度在45min时小于90%,均不符合中国药典的相关规定,说明本发明提供的胶囊剂配方合理,可以大大的提高产品质量,促进壳寡糖胶囊剂的推广和应用。It can be seen from Table 1 that the contents of the shell oligosaccharide capsules prepared in Examples 1-4 of the present invention are dry, moderately tight, and the moisture content is less than 9.0%, and the capsule has no peculiar smell, and the appearance is neat, without sticking, deformation, and seepage. Leakage or capsule rupture, its loading difference and solubility are in line with the relevant provisions of the Chinese Pharmacopoeia, while the capsules prepared in Comparative Example 1 and Comparative Example 2 have irregularities in appearance, such as sticking, deformation, leakage or rupture of the shell. The dissolution rate is less than 90% at 45 min, which does not comply with the relevant regulations of the Chinese Pharmacopoeia, indicating that the capsule formulation provided by the invention is reasonable, can greatly improve the product quality, and promote the promotion and application of the chitosan oligosaccharide capsule.
试验例二、壳寡糖胶囊剂的加速试验Test Example 2, Accelerated test of chitosan oligosaccharide capsules
1、试验材料:实施例1、实施例2、实施例3、实施例4、对比例1和对比例2制备的壳寡糖胶囊剂。1. Test materials: Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2.
2、试验方法:2. Test method:
参考《中国药典2010年版二部附录XIX C》的试验方法,对实施例1、实施例2、实施例3、实施例4、对比例1和对比例2制备的壳寡糖胶囊剂进行加速试验。The accelerated test of chitosan oligosaccharide capsules prepared in Example 1, Example 2, Example 3, Example 4, Comparative Example 1 and Comparative Example 2 was carried out with reference to the test method of "Chinese Pharmacopoeia 2010 Edition Part II Appendix XIX C". .
3、试验结果:3. Test results:
试验结果如表2。 The test results are shown in Table 2.
表2 壳寡糖胶囊剂的加速试验结果Table 2 Accelerated test results of chitosan oligosaccharide capsules
Figure PCTCN2016102114-appb-000002
Figure PCTCN2016102114-appb-000002
由表2可知,本发明实施例1-4制备的壳寡糖胶囊剂在温度为40℃±2℃、相对湿度为75%±5%的条件下放置6个月,其各项指标均符合中国药典对胶囊剂的质量要求,而对比例1和对比例2制备的壳寡糖胶囊剂的稳定性均比实施例1-4制备的壳寡糖胶囊剂差,说明本发明提供的壳寡糖胶囊剂配方合理,大大的提高了壳寡糖胶囊剂的稳定性。It can be seen from Table 2 that the chitosan oligosaccharide capsules prepared in Examples 1-4 of the present invention are placed under the conditions of temperature of 40 ° C ± 2 ° C and relative humidity of 75% ± 5% for 6 months, and the indexes thereof are all in accordance with The quality requirements of the Chinese Pharmacopoeia for the capsules, while the stability of the chitosan oligosaccharide capsules prepared in Comparative Example 1 and Comparative Example 2 were inferior to those of the chitosan oligosaccharide capsules prepared in Examples 1-4, indicating the shell oligomer provided by the present invention. The formula of the sugar capsule is reasonable, and the stability of the chitosan oligosaccharide capsule is greatly improved.
试验例三、壳寡糖胶囊剂的长期试验Test Example 3: Long-term test of chitosan oligosaccharide capsules
1、试验材料:实施例1、实施例2、实施例3和实施例4制备的壳寡糖胶囊剂。1. Test materials: Shell oligosaccharide capsules prepared in Example 1, Example 2, Example 3 and Example 4.
2、试验方法:2. Test method:
参考《中国药典2010年版二部附录XIX C》的试验方法,对实施例1、实施例2、实施例3和实施例4制备的壳寡糖胶囊剂进行长期试验。The chitosan oligosaccharide capsules prepared in Example 1, Example 2, Example 3 and Example 4 were subjected to long-term tests with reference to the test method of "Chinese Pharmacopoeia 2010 Edition Part II Appendix XIX C".
3、试验结果:3. Test results:
试验结果如表3。The test results are shown in Table 3.
表3 壳寡糖胶囊剂的长期试验结果Table 3 Long-term test results of chitosan oligosaccharide capsules
Figure PCTCN2016102114-appb-000003
Figure PCTCN2016102114-appb-000003
由表3可知,本发明实施例1-4制备的壳寡糖胶囊剂在温度为25℃±2℃、相对湿度为60%±10%的条件下放置12个月,其各项指标均符合中国药典对胶囊剂的质量要求,说明本发明提供的胶囊剂稳定性高,防潮效果好,有利于该胶囊剂的保存。 It can be seen from Table 3 that the chitosan oligosaccharide capsules prepared in Examples 1-4 of the present invention are placed under the conditions of a temperature of 25 ° C ± 2 ° C and a relative humidity of 60% ± 10% for 12 months, and the indexes thereof are in accordance with The Chinese Pharmacopoeia's quality requirements for capsules indicate that the capsules provided by the present invention have high stability and good moisture-proof effect, which is beneficial to the preservation of the capsules.

Claims (10)

  1. 一种壳寡糖胶囊剂,其特征在于,包括内容物和囊壳,所述内容物包括如下组分及其重量百分比:壳寡糖80-100%、微晶纤维素0-6%、黏合剂0-5%、硬脂酸钙0-3%、乙醇0-4%和微粉硅胶0-2%;A chitosan oligosaccharide capsule comprising a content and a capsule comprising the following components and their weight percentages: chitosan oligosaccharide 80-100%, microcrystalline cellulose 0-6%, adhesive Agent 0-5%, calcium stearate 0-3%, ethanol 0-4% and micronized silica gel 0-2%;
    所述囊壳包括如下组分及其重量份数:羟丙基淀粉4-10份、黄原胶2-6份、增稠剂4-8份、增塑剂3-6份和水10-20份。The capsule comprises the following components and parts by weight: 4-10 parts of hydroxypropyl starch, 2-6 parts of xanthan gum, 4-8 parts of thickener, 3-6 parts of plasticizer and 10 parts of water. 20 copies.
  2. 如权利要求1所述的壳寡糖胶囊剂,其特征在于,所述内容物包括如下组分及其重量百分比:壳寡糖80-92%、微晶纤维素2-6%、黏合剂2-5%、硬脂酸钙1-3%、乙醇2-4%和微粉硅胶1-2%。The chitosan oligosaccharide capsule according to claim 1, wherein the content comprises the following components and their weight percentages: chitosan oligosaccharide 80-92%, microcrystalline cellulose 2-6%, binder 2 -5%, 1-3% calcium stearate, 2-4% ethanol and 1-2% silica gel.
  3. 如权利要求2所述的壳寡糖胶囊剂,其特征在于,所述内容物包括如下组分及其重量百分比:壳寡糖85.5%、微晶纤维素4%、黏合剂4%、硬脂酸钙2%、乙醇3%和微粉硅胶1.5%。The chitosan oligosaccharide capsule according to claim 2, wherein the content comprises the following components and their weight percentages: chitosan oligosaccharide 85.5%, microcrystalline cellulose 4%, binder 4%, stearin Calcium acid 2%, ethanol 3% and fine powder silica gel 1.5%.
  4. 如权利要求1-3任一所述的壳寡糖胶囊剂,其特征在于,所述黏合剂为浓度为5%的聚维酮溶液,所述乙醇为无水乙醇。The chitosan oligosaccharide capsule according to any one of claims 1 to 3, wherein the binder is a povidone solution having a concentration of 5%, and the ethanol is anhydrous ethanol.
  5. 如权利要求1所述的壳寡糖胶囊剂,其特征在于,所述囊壳包括如下组分及其重量份数:羟丙基淀粉8份、黄原胶4份、增稠剂5份、增塑剂4份和水16份。The chitosan oligosaccharide capsule according to claim 1, wherein the capsule comprises the following components and parts by weight: hydroxypropyl starch 8 parts, xanthan gum 4 parts, thickener 5 parts, 4 parts of plasticizer and 16 parts of water.
  6. 如权利要求1或5所述的壳寡糖胶囊剂,其特征在于,所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1-2:3-4组成。The chitosan oligosaccharide capsule according to claim 1 or 5, wherein the thickener is composed of guar gum and propylene glycol alginate in a weight ratio of 1-2:3-4.
  7. 如权利要求6所述的壳寡糖胶囊剂,其特征在于,所述增稠剂由瓜尔豆胶和藻酸丙二醇酯按重量比1.2:3.5组成。The chitosan oligosaccharide capsule according to claim 6, wherein the thickener is composed of guar gum and propylene glycol alginate at a weight ratio of 1.2:3.5.
  8. 如权利要求1或5所述的壳寡糖胶囊剂,其特征在于,所述增塑剂由甘油和柠檬酸三乙酯按重量比2-4:1-3组成。The chitosan oligosaccharide capsule according to claim 1 or 5, wherein the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 2-4:1-3.
  9. 如权利要求6所述的壳寡糖胶囊剂,其特征在于,所述增塑剂由甘油和柠檬酸三乙酯按重量比3.5:2组成。The chitosan oligosaccharide capsule according to claim 6, wherein the plasticizer is composed of glycerin and triethyl citrate in a weight ratio of 3.5:2.
  10. 一种如权利要求1-9任一所述的壳寡糖胶囊剂的制备方法,其特征在于,包括以下步骤:A method for preparing a chitosan oligosaccharide capsule according to any one of claims 1-9, comprising the steps of:
    S1将壳寡糖、微晶纤维素、硬脂酸钙和微粉硅胶研磨成细粉,加入黏合剂和乙醇混合均匀,过18-25目筛,得细粉;S1 grinds chitosan oligosaccharide, microcrystalline cellulose, calcium stearate and micro-powder silica gel into a fine powder, and mixes with a binder and ethanol to pass through a sieve of 18-25 mesh to obtain a fine powder;
    S2将步骤S1得到的细粉进行湿法制粒,所述湿法制粒的温度为22-28℃,湿度为35-45%,制粒后干燥至水分少于10%,得内容物; S2, the fine powder obtained in the step S1 is subjected to wet granulation, the wet granulation temperature is 22-28 ° C, the humidity is 35-45%, and the granulation is dried to less than 10% moisture to obtain a content;
    S3将羟丙基淀粉研磨成细粉,加入黄原胶、增稠剂、增塑剂和水混合均匀,在温度为55-60℃的条件下干燥4-5h,接着在温度为50℃下进行蘸胶,烘干,脱模,切割,套合,得囊壳;S3 grinds the hydroxypropyl starch into a fine powder, adds xanthan gum, thickener, plasticizer and water to mix evenly, and dries at a temperature of 55-60 ° C for 4-5 h, then at a temperature of 50 ° C Carrying out silicone, drying, demoulding, cutting, nesting, and obtaining a capsule;
    S4将步骤S2得到的内容物灌装到步骤S3得到的囊壳中,将胶囊密封,即得。 S4, the content obtained in step S2 is filled into the capsule obtained in step S3, and the capsule is sealed.
PCT/CN2016/102114 2015-12-24 2016-10-14 Chitosan oligosaccharide capsule and method for preparation thereof WO2017107628A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510988017.7A CN105380924B (en) 2015-12-24 2015-12-24 A kind of chitosan oligosaccharide capsule agent and preparation method thereof
CN2015109880177 2015-12-24

Publications (1)

Publication Number Publication Date
WO2017107628A1 true WO2017107628A1 (en) 2017-06-29

Family

ID=55414106

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/102114 WO2017107628A1 (en) 2015-12-24 2016-10-14 Chitosan oligosaccharide capsule and method for preparation thereof

Country Status (2)

Country Link
CN (1) CN105380924B (en)
WO (1) WO2017107628A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022194351A1 (en) 2021-03-16 2022-09-22 Symrise Ag Active substance capsules
WO2023184828A1 (en) * 2022-03-30 2023-10-05 扬州日兴生物科技股份有限公司 Nano microsphere for improving oral bioavailability of chitosan oligosaccharide, and preparation method therefor

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380924B (en) * 2015-12-24 2018-01-16 广东药科大学 A kind of chitosan oligosaccharide capsule agent and preparation method thereof
CN108186701A (en) * 2018-02-08 2018-06-22 沈勇子 A kind of chitosan oligosaccharide capsule and preparation method thereof
CN108553426B (en) * 2018-06-01 2020-04-03 广东药科大学 Chitosan dropping pill and preparation method thereof
CN108578374B (en) * 2018-06-01 2020-04-03 广东药科大学 Chitosan oligosaccharide granules and preparation method thereof
CN109316460B (en) * 2018-09-26 2021-11-26 青岛大学 Preparation method of polysaccharide polyelectrolyte hollow capsule and hollow capsule obtained by preparation method
CN114376982B (en) * 2022-01-18 2023-06-30 广东药科大学 Chitosan oligosaccharide enteric-coated capsule as well as preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101416979A (en) * 2007-10-24 2009-04-29 中国科学院大连化学物理研究所 Use of oligosaccharide in preparing medicine for treating tumor and inhibiting tumor metastasis
CN101744164A (en) * 2009-12-29 2010-06-23 江西省三抗保健品有限公司 Chitosan oligosaccharide capsule
CN104586877A (en) * 2015-02-10 2015-05-06 河北工业大学 Chitosan oligosaccharide-containing pharmaceutical composition and applications thereof
CN105380924A (en) * 2015-12-24 2016-03-09 广东药学院 Chtiosnaoligosaccharide (COS) capsule and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2848473B1 (en) * 2002-12-16 2008-04-11 Laurence Paris VISCOUS, AQUEOUS OR HYDRO ALCOHOLIC COMPOSITIONS, TAMPONED OR NOT, FOR THE MANUFACTURE OF SOFT CAPSULES, AND PROCESS FOR PRODUCING FILMS THEREFROM
CN104721167A (en) * 2015-03-09 2015-06-24 湖南尔康制药股份有限公司 Starch soft capsules

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101416979A (en) * 2007-10-24 2009-04-29 中国科学院大连化学物理研究所 Use of oligosaccharide in preparing medicine for treating tumor and inhibiting tumor metastasis
CN101744164A (en) * 2009-12-29 2010-06-23 江西省三抗保健品有限公司 Chitosan oligosaccharide capsule
CN104586877A (en) * 2015-02-10 2015-05-06 河北工业大学 Chitosan oligosaccharide-containing pharmaceutical composition and applications thereof
CN105380924A (en) * 2015-12-24 2016-03-09 广东药学院 Chtiosnaoligosaccharide (COS) capsule and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022194351A1 (en) 2021-03-16 2022-09-22 Symrise Ag Active substance capsules
WO2023184828A1 (en) * 2022-03-30 2023-10-05 扬州日兴生物科技股份有限公司 Nano microsphere for improving oral bioavailability of chitosan oligosaccharide, and preparation method therefor

Also Published As

Publication number Publication date
CN105380924B (en) 2018-01-16
CN105380924A (en) 2016-03-09

Similar Documents

Publication Publication Date Title
WO2017107628A1 (en) Chitosan oligosaccharide capsule and method for preparation thereof
CN104886554A (en) Pomander soft capsule and preparation method thereof
CN105496981B (en) A kind of chitosan oligosaccharide tablet and preparation method thereof
BRPI0924653B1 (en) FERRO-OLIGOSACARIDE COMPOUND, COMPOSITION AND USE OF THIS COMPOUND
US11576870B2 (en) Pullulan capsules
CN103040728A (en) Chitosan gel for women as well as preparation method and medical application thereof
CN103251572B (en) Preparation method of theaflavin enteric microcapsule, as well as product prepared by preparation method and application of product
CN103191072A (en) Simvastatin tablets and preparation method thereof
Muthusamy et al. Microbial pullulan for food, biomedicine, cosmetic, and water treatment: a review
CN104998268A (en) Acarbose drug combination and preparing method thereof
Nep et al. Pharmaceutical properties and applications of a natural polymer from Grewia mollis
CN103211753A (en) Gel matrix
CN102488663B (en) Drug combination containing ethylenediamine diaceturate and preparing method thereof
CN103463125B (en) Gel preparation for treating gynecological diseases and preparation method thereof
CN105053773B (en) A kind of black garlic FOS piece and preparation method thereof
CN103040729A (en) Chitosan gel for removing acne scars as well as preparation method and medical application thereof
JP6800861B2 (en) Method for manufacturing thickening polysaccharide-containing preparation
JP5805522B2 (en) Powder composite and wound dressing
CN110507629B (en) Plant cellulose soft capsule rubber and preparation method thereof
CN108324957A (en) A kind of S- carboxymethyls-L-cysteine inclusion compound and its enteric-coated formulation composition
CN110074387B (en) Temperature-control food thickening component with special medical purpose formula and preparation method thereof
CN102327233A (en) Dimercaptosuccinic acid granular formulation
KR20190035623A (en) Edible compositions for reducing the digestion or absorption of harmful / toxic substances
WO2019227746A1 (en) Chitosan oral solution and preparation method therefor
EP3764984A1 (en) Highly stable formulations of thyroid hormone in soft capsules

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16877439

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 30.08.2018)

122 Ep: pct application non-entry in european phase

Ref document number: 16877439

Country of ref document: EP

Kind code of ref document: A1